Prioritization of Anti-SARS-Cov-2 Drug Repurposing Opportunities Based on Plasma and Target Site Concentrations Derived from their Established Human Pharmacokinetics. (2020)

First Author: Arshad U
Attributed to:  MICA: New combination therapy against MDR TB targeting the respiratory chain funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1002/cpt.1909

PubMed Identifier: 32438446

Publication URI: http://europepmc.org/abstract/MED/32438446

Type: Journal Article/Review

Volume: 108

Parent Publication: Clinical pharmacology and therapeutics

Issue: 4

ISSN: 0009-9236